Advertisement
U.S. Markets closed

Edwards Lifesciences Corporation (EWL.DE)

XETRA - XETRA Delayed Price. Currency in EUR
64.34-1.56 (-2.37%)
At close: 05:35PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 38.61B
Enterprise Value 37.42B
Trailing P/E 29.51
Forward P/E 27.47
PEG Ratio (5 yr expected) 3.71
Price/Sales (ttm)7.52
Price/Book (mrq)5.64
Enterprise Value/Revenue 7.25
Enterprise Value/EBITDA 28.10

Trading Information

Stock Price History

Beta (5Y Monthly) 1.13
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 388.64
52 Week Low 354.00
50-Day Moving Average 361.75
200-Day Moving Average 374.45

Share Statistics

Avg Vol (3 month) 3586
Avg Vol (10 day) 3444
Shares Outstanding 5602.4M
Implied Shares Outstanding 6N/A
Float 8596.35M
% Held by Insiders 10.90%
% Held by Institutions 186.87%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Sep 30, 2024

Profitability

Profit Margin 65.86%
Operating Margin (ttm)29.11%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)6.31B
Revenue Per Share (ttm)10.50
Quarterly Revenue Growth (yoy)-8.50%
Gross Profit (ttm)N/A
EBITDA 2.06B
Net Income Avi to Common (ttm)1.57B
Diluted EPS (ttm)2.18
Quarterly Earnings Growth (yoy)697.80%

Balance Sheet

Total Cash (mrq)1.99B
Total Cash Per Share (mrq)3.3
Total Debt (mrq)693M
Total Debt/Equity (mrq)9.23
Current Ratio (mrq)N/A
Book Value Per Share (mrq)12.35

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A